美国Islet Sciences  
糖尿病研究

Islet Sciences is a biotechnology company engaged in the research, development and commercialization of patented technologies in the field of transplantation therapy for patients with diabetes.

Islet Sciences has entered into several collaborations with prestigious diabetes research groups. These collaborations allow the Company to pursue a wide variety of cell transplantation technologies.

Islet Sciences is continually inventing and exploring new avenues of research and development, and welcomes inquiry from potential collaborators.

Read Our Code Of Business Conduct And Ethics

OUR MISSION
Islet Sciences' mission is to dramatically improve the health and quality of life for people with insulin-dependent diabetes through the development of novel cell transplantation therapies. We believe our xenotransplantation approach and proprietary microencapsulation technology will overcome many obstacles to cell transplantation and may enable insulin-dependent diabetes patients to become free of insulin injections.